Teva completes deal for second migraine-treatment developer

Teva Pharmaceutical Industries Ltd. completed its previously announced acquisition of Labrys in a deal that strengthens the generic and branded pharmaceutical company’s presence in the migraine headache treatment and central nervous system disorder arena...